Join the SmallCapReview mailing list.

Small Cap Stocks On The Radar

MYGN Myriad Genetics: A  personalized medicine company, that focuses on the development and marketing of predictive, personalized, and prognostic medicine tests worldwide. MYGN has a collaboration with AstraZeneca for the development of an indication for BRACAnalysis CDx. More.                      
SCLN SciClone Pharmaceuticals: A revenue-generating, specialty pharmaceutical company with a substantial commercial business in China and a product portfolio spanning major therapeutic markets including oncology, infectious diseases and cardiovascular disorders. More.     
ICPT Intercept Pharmaceuticals: A biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat orphan and more prevalent liver diseases utilizing its expertise in bile acid chemistry.  OCA has received orphan drug designation in both the United States and Europe for the treatment of PBC. More.                 
Commentary

Microcap Stocks - There's A Lot To Like About Them


Small Cap Stocks - Time For Active Investing


Compelling Reasons To Keep Small Caps


Charts Say Go Long Small Caps In February


5 Small Cap Picks


Markets
Volume Leaders
Advancers/Decliners
52 Week Highs/Lows
Small-Cap Index
Tools
Check Futures Here
Quotes
Level II Quotes
Stock Screener
Performance by Industry
Pre-Market
After Hours Market
World Markets
Education

 

Visit Our Resources Page

Past Articles Worth Reading

 

 

 

 


 

 

 

 

 

 

 

 Where Small Cap Stocks Thrive Since 1999                                           

Why Do Alpha Seekers Find It In Small Caps?

 Fewer than 40% of large-cap managers outperform U.S. large-cap equity. More than 60% of their small-cap counterparts do so.


10 High Yield Small Cap Dividend Stocks For 2017...

MYGN's BRACAnalysis CDx® Test Successfully Identified Metastatic Breast Cancer Patients with Improved Outcomes from AstraZeneca's...(MYGN)

MYGN's Prolaris® Test Significantly Improves the Risk Classification for One Third of Men Diagnosed with Localized Prostate Cancer...(MYGN)

MYGN Joins Small Cap 600...(MYGN)

A Most Wonderful Year For Small Caps...

The Next Leg Of The Small Cap Rally Starts Now...

Why Small Caps Remain Some Of The Top Stocks To Invest In...

Small Cap Stocks Hit Record High...

The Long And Short Of Small Cap Options...

U.S. Markets Reach New Highs... In small-caps, the Russell 2000 Index closed at 1378.53 for a gain of 19.79 points or 1.46%.


Myriad Genetics (MYGN)

Website: www.Myriad.com

"Myriad has the deepest diagnostic pipeline across the disease spectrum."

More on MYGN here...


SciClone Pharmaceuticals (SCLN)

"SciClone Has Raised It's EPS Guidance"

More on SCLN here...


Intercept Pharmaceuticals (ICPT)

 

"A Biopharmaceutical Company Focused On The Development And Commercialization Of Novel Therapeutics To Treat Chronic Liver Diseases."

More on ICPT here...


Follow Us On

Twitter


4 Small Caps To Look At


Small Cap Stocks And Emerging Markets Ripe For Growth


How To Play The Small Cap Comeback


Small Cap Stocks Are Poised For Big Gains


The State Of Microcaps - A Look Back At 2016 And Into The Future


These Small Caps Are Expected To Rise 31% Or More In 2017


Small Caps Tend To Benefit More Under Trump


Quality: A Driving Factor In Small Cap Returns


Quantitative Review Of Small Cap Value


5 Small Caps For 2017


Trump Brings Tailwinds To Small Caps


Right Now In Stocks, Small Is Big


5 Charts: Small Caps With A Bull Flag


Small Cap ETFs For A New Era


Trump, Rolling Stones


Year End Review: Small Cap Stocks


A Rebound For Small Caps And The Rally Has Room To Run


13 Small Caps With Bullish Setups For 2017


What To Expect From Small Caps With The Tick Size Pilot Program


4 Reasons To Weight Your Portfolio To Small Cap Growth


Small Caps Eye Key Breakout


Small Cap Stocks Leading The Trump Rally


How To Trade A Santa Claus Rally. Hint: Small Caps


Futures Traders Loving Small Caps While Shorting S&P 500



Subscribers to our Free newsletter will receive stock reports and news alerts for small-cap stocks via email. You can sign-up here.


 

"A Primer In Microcap Investing"

SmallCapReview.com® is a leading destination for small-cap picks and news. The Purpose of SmallCapReview.com is to profile and bring awareness to companies with a market cap of less than $1 billion, these small-cap stocks will primarily trade on the Nasdaq Small-Cap market. We also issue daily small cap stocks to watch via various newswires. We will strive to bring you the undiscovered, the undervalued, and the oversold. SmallCapReview.com does not give "buy" recommendations, price targets nor suggest entry and exit points.

"A Look at Small Cap Stocks that may no longer be Small Caps"

 

 

 


B
© 1999-2017 SmallCapReview.com. Any questions or comments regarding this site should be directed to editor@smallcapreview.com